Quality of Cardiovascular Drugs Prescribing in Croatia 2003-2008

被引：2

作者：

Stimac, Danijela ^{[1
,2
]}

机构：

[1] Univ Zagreb, Sch Med, Andrija Stampar Sch Publ Hlth, Dept Social Med, Zagreb 10000, Croatia

[2] Org Hlth Care, Zagreb, Croatia

来源：

COLLEGIUM ANTROPOLOGICUM | 2012年 / 36卷

关键词：

cardiovascular; drugs; prescribing; ATC/DDD methodology; Croatia; ONSET ATRIAL-FIBRILLATION; STABLE ANGINA-PECTORIS; ORAL PROPAFENONE; HYPERTENSION; PREVENTION; ATENOLOL; POPULATION; AMIODARONE; INDAPAMIDE; AMLODIPINE;

D O I：

10.5671/ca.2012361s.189

中图分类号：

Q98 [人类学];

学科分类号：

030303 ;

摘要：

The aim of the study was to determine cardiovascular drugs utilization and quality of prescribing in Croatia from 2003 to 2008. Data on the outpatient utilization of cardiovascular drugs in Croatia were collected during 2003-2008. Data on the size and number of packages, were obtained from Croatian institute for Health Insurance (CIHI). Based on the data obtained, the numbers of DDD and DDD per 1000 inhabitants per day (DDD/1000/day) were calculated for all cardiovascular drugs. Quality of drugs prescribing was assessing using Drug Utilization 90% (DU90%) method. Renin-angiotensin system agents showed highest share in the utilization of group C drugs, followed by calcium channel blockers. These two groups of drugs accounted for half of the overall cardiovascular drug utilization. Greatest changes were observed in the groups of renin-angiotensin system agents and hypolipemics. The number of drugs within DU90% segment increased between 2003 and 2008. In the same period Cost/DDD decreased.

引用

页码：189 / 194

页数：6

共 57 条

[1]

[Anonymous], 2009, CROAT HLTH STAT ANN

[2]

[Anonymous], AN THER CHEM ATC CLA

[3]

[Anonymous], 2007, AN THER CHEM ATC CLA

[4]

[Anonymous], 2005, OFFICIAL GAZETTE REP, V87

[5]

Basile Jan, 2004, J Clin Hypertens (Greenwich), V6, P621, DOI 10.1111/j.1524-6175.2004.03683.x

[6] Drug utilization 90% -: a simple method for assessing the quality of drug prescribing [J].

Bergman, U ;

Popa, C ;

Tomson, Y ;

Wettermark, B ;

Einarson, TR ;

Åberg, H ;

Sjöqvist, F .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (02) :113-118

[7] Angiotensin receptor blockers versus angiotensin-converting enzyme inhibitors:: Where do we stand now? [J].

Boehm, Michael .

AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (3A) :38J-44J

[8] Safety of oral propafenone in the conversion of recent onset atrial fibrillation to sinus rhythm: A prospective parallel placebo-controlled multicentre study [J].

Capucci, A ;

Villani, GQ ;

Aschieri, D ;

Piepoli, M .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 1999, 68 (02) :187-196

[9] Congestive heart failure: What should be the initial therapy and why? [J].

Chatterjee K. .

American Journal of Cardiovascular Drugs, 2002, 2 (1) :1-6

[10] Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema [J].

Cotter, G ;

Metzkor, E ;

Kaluski, E ;

Faigenberg, Z ;

Miller, R ;

Simovitz, A ;

Shaham, O ;

Marghitay, D ;

Koren, M ;

Blatt, A ;

Moshkovitz, Y ;

Zaidenstein, R ;

Golik, A .

LANCET, 1998, 351 (9100) :389-393

← 1 2 3 4 5 6 →